| [1] |
Huang WW, Tsao SM, Lai CL, et al. Diagnostic value of Her-2/ neu,Cyfra21-1,and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma[J]. Pathology, 2010, 42 (3): 224-8.
|
| [2] |
Gu P, Huang G, Chen Y, et al. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis[J]. J Clin Lab Anal, 2007, 21(6): 398-405.
|
| [3] |
Shitrit D, Zingerman B, Shitrit AB, et al. Diagnostic value of CYFRA 21-1, CEA, CA19-9, CA15-3, and CA125 assays in pleural effusions: analysis of 116 cases and review of the literature[J]. Oncologist, 2005, 10(7): 501-7.
|
| [4] |
Katayama H, Hiraki A, Aoe K, et al. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion[J]. Int J Cancer, 2007, 120(10): 2191-5.
|
| [5] |
Wang T, Qian X, Wang Z, et al. Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions[J]. Int J Cancer, 20 09, 125(8): 1921-5.
|
| [6] |
Roth C, Stückrath I, Pantel K, et al. Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors[J]. PLoS One, 20 12, 7(6): e38248.
|
| [7] |
Fleischhacker M, Schmidt B. Free circulating nucle icacids in plasma and serum(CNAPS)-Useful for the detection of lung cancer patients?[J]. Cancer Biomark, 2010, 6(3-4): 211-9.
|
| [8] |
Zhou L, Zhao YP, Liu WJ, et al. Circulating microRNAs in cancer: diagnostic and prognostic significance[J]. Expert Rev Anticancer Ther, 2012, 12(2): 283-8.
|
| [9] |
Cho WC. Circulating MicroRNAs as minimally invasive biomarkers for cancer theragnosis and prognosis[J]. Front Genet, 20 11, 2: 7.
|
| [10] |
Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids-the mix of hormones and biomarkers[J]. Nat Rev Clin Oncol, 2011, 8(8): 467-77.
|
| [11] |
Etheridge A1, Lee I, Hood L, et al. Extracellular microRNA:a new source of biomarkers[J]. Mutat Res, 2011, 717(1-2): 85-90.
|
| [12] |
Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids[J]. Clin Chem, 2010, 56(11): 1733-41.
|
| [13] |
Catto JW, Alcaraz A, Bjartell AS, et al. MicroRNA in prostate, bladder, and kidney cancer:a systematic review[J]. Eur Urol, 20 11, 59(5): 671-81.
|
| [14] |
Schaefer A, Jung M, Mollenkopf HJ, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma[J]. Int J Cancer, 2010, 126(5): 1166-76.
|
| [15] |
Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer[J]. Nat Rev Cancer, 2006, 6(4): 259-69.
|
| [16] |
Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles inhuman plasma[J]. Proc Natl Acad Sci U S A, 2011, 10 8(12): 5003-8.
|
| [17] |
Rayner KJ, Hennessy EJ. Extracellular communication via microRNA: lipid particles have a new message[J]. J Lipid Res, 20 13, 54(5): 1174-81.
|
| [18] |
Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by highdensity lipoproteins[J]. Nat Cell Biol, 2011, 13(4): 423-33.
|
| [19] |
Reid G1, Kirschner MB, van Zandwjk N. Circulating microRNAs: association with disease and potential use as biomarkers[J]. Crit Rev Oncol Hematol, 2011, 80(2): 193-208.
|
| [20] |
Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5’UTR as in the 3’ UTR[J]. Proc Natl Acad Sci U S A, 2007, 104(23): 9667-72.
|
| [21] |
Qin W, Shi Y, Zhao B, et al. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells[J]. PLoS One, 2010, 5(2): e9429.
|
| [22] |
Xie L, Chen X, Wang L, et al. Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions[J]. BMC Cancer, 2010, 10: 591.
|
| [23] |
Xie L, Wang T, Yu S, et al. Cell-free miR-24 and miR- 30 d,potential diagnostic biomarkers in malignant effusions[J]. Clin Biochem, 2011, 44(2-3): 216-20.
|
| [24] |
Gee GV, Koestler DC, Christensen BC, et al. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma[J]. Int J Cancer, 2010, 127(12): 2859-69.
|
| [25] |
Han HS, Yun J, Lim SN, et al. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinomaassociated malignant pleural effusion[J].Int J Cancer, 2013, 13 3(3): 645-52.
|
| [26] |
Gu P, Huang G, Chen Y, et al. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and Meta-analysis[J]. J Clin Lab Anal, 2007, 21(6): 398-405.
|
| [27] |
Wang T, Lv M, Shen S, et al. Cell-free microRNA expression profiles in malignant effusion associated with patient survival innon-small cell lung cancer[J]. PLoS One, 2012, 7(8): e43268.
|
下载:
